易鑫(02858.HK)获联交所豁免严格遵守最低公众持股量规定
易鑫集团(02858.HK)公布,紧随要约截止後,待完成向联席要约人转让彼等根据要约收购的相关要约股份後,公众人士持有11.82亿股公司股份,占公司於要约截止公告日期的全部已发行股本约18.53%。根据联交所就股份给予的豁免,公司所适用的最低公众持股量为已发行股份的22.99%。因此公司最低公众持股量规定未获满足。
於要约截止後,公司已向联交所申请,於今年12月2日至明年4月1日止期间,临时豁免严格遵守上市规则第8.08(1)(a)条的规定。於今年12月18日,联交所已向公司授出临时豁免,於豁免期内宽免严格遵守上市规则有关规定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.